➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKesson
McKinsey
Medtronic
Colorcon

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DIFLUCAN IN SODIUM CHLORIDE 0.9%

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Diflucan In Sodium Chloride 0.9%

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00189709 ↗ Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia Completed Astellas Pharma Taiwan, Inc. Phase 3 2004-08-01 To determine the efficacy and safety of micafungin (FK463) versus fluconazole (Diflucan) in treating patients with invasive candidiasis or candidaemia
NCT00189709 ↗ Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia Completed Astellas Pharma Inc Phase 3 2004-08-01 To determine the efficacy and safety of micafungin (FK463) versus fluconazole (Diflucan) in treating patients with invasive candidiasis or candidaemia
NCT00350818 ↗ Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) Completed Celgene Corporation Phase 1 2005-10-01 Primary Objective: -To determine the dose and schedule combination of 5-Azacitidine, when used as maintenance treatment after allogeneic transplantation for high-risk AML / MDS. Secondary Objective: -To assess the effect of treatment on survival after allogeneic transplantation for high-risk AML / MDS.
NCT00350818 ↗ Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) Completed M.D. Anderson Cancer Center Phase 1 2005-10-01 Primary Objective: -To determine the dose and schedule combination of 5-Azacitidine, when used as maintenance treatment after allogeneic transplantation for high-risk AML / MDS. Secondary Objective: -To assess the effect of treatment on survival after allogeneic transplantation for high-risk AML / MDS.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Diflucan In Sodium Chloride 0.9%

Condition Name

Condition Name for Diflucan In Sodium Chloride 0.9%
Intervention Trials
Candidiasis 4
Healthy 3
Bioequivalence 2
Leukemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Diflucan In Sodium Chloride 0.9%
Intervention Trials
Candidiasis 7
Mycoses 3
Vaginitis 2
Leukemia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Diflucan In Sodium Chloride 0.9%

Trials by Country

Trials by Country for Diflucan In Sodium Chloride 0.9%
Location Trials
United States 23
Canada 3
Switzerland 2
India 1
Taiwan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Diflucan In Sodium Chloride 0.9%
Location Trials
New York 3
North Carolina 2
Minnesota 2
Texas 2
South Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Diflucan In Sodium Chloride 0.9%

Clinical Trial Phase

Clinical Trial Phase for Diflucan In Sodium Chloride 0.9%
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Phase 2 2
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Diflucan In Sodium Chloride 0.9%
Clinical Trial Phase Trials
Completed 11
Not yet recruiting 6
Recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Diflucan In Sodium Chloride 0.9%

Sponsor Name

Sponsor Name for Diflucan In Sodium Chloride 0.9%
Sponsor Trials
Pfizer 3
Dr. Reddy's Laboratories Limited 2
Astellas Pharma Inc 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Diflucan In Sodium Chloride 0.9%
Sponsor Trials
Other 17
Industry 14
NIH 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Merck
McKesson
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.